The outlook of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key markets has introduced significant uncertainty . Investors are now grappling with the impact of lower-cost alternatives,